Global OTC Drugs Market - PR

1. Global OTC Drugs Market to Expand from 2023-2035 at a CAGR of ~7%: Says Kenneth Research: Worldwide Practice of Self Medication and the Seasonal Recurring of Influenza to Drive the Growth Kenneth Research published a report titled “OTC Drugs Market: Global Demand Analysis & Opportunity Outlook 2035” which delivers detailed overview of the global OTC drugs market in terms of market segmentation by product type, dosage form, route of administration, distribution channel, and by region. Further, for the in-depth analysis, the report encompasses the industry growth indicators, restraints, supply and demand risk, along with detailed discussion on current and future market trends that are associated with the growth of the market. Kenneth Research projects the global OTC drugs market to witness growth from ~USD 151 billion in 2022 to ~USD 294 billion in 2035. The market growth is expected to occur as a result of several factors, including self-medication for treating specific symptoms, the recurrence of seasonal influenza, the cost-effectiveness of over-the-counter (OTC) drugs, the geriatric population, and the growth of online pharmacies.

2. Further, the global OTC drugs market is projected to grow at a CAGR of ~7% during the forecast period. The market is segmented by route of application into oral, parental, topical, and others. Of these, the orally administrated segment is anticipated to hold the largest market share by the end of 2035, owing to its safety, convenience, and cost- effectiveness. For more information’s@https://www.kennethresearch.com/report-details/otc-drugs- market-/10352513 The regional markets of North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa constitute the global OTC drugs market. Of these, the market in the European region is expected to show the most significant growth for the spike in the sales of OTC drugs, awareness about the usage of OTC drugs, and the evolution of online pharmacies. The research is global in nature and covers detailed analysis on the market in North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC [Finland, Sweden, Norway, Denmark], Poland, Turkey, Russia, Rest of Europe), Latin America (Brazil, Mexico, Argentina, Rest of Latin America), Asia-Pacific (China, India, Japan, South Korea, Indonesia, Singapore, Malaysia, Australia, New Zealand, Rest of Asia-Pacific), Middle East and Africa (Israel, GCC [Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of Middle East and Africa). In addition, analysis comprising market size, Y-O-Y growth & opportunity analysis, market players’ competitive study, investment opportunities, demand for future outlook etc. has also been covered and displayed in the research report. Recurrence of Seasonal Influenza to Encourage the Market Growth Influenza has been observed to cause up to 5 million cases of grave illness and up to 650001 respiratory deaths every year. Influenza usually occurs in the winter or places of low temperature. Then the dehydration of the mucus membrane due to the cold makes it easier for respiratory

3. viruses to enter the body. This leads to widespread viral influenza accompanied by several symptoms, such as headache, chills, cough, runny nose, and more. Many of these symptoms could be self-diagnosed and treated effectively with OTC medicines, thus boosting market growth. However, strict regulations of the government, reactions of OTC medicines with other medicines, and people with specific medical conditions operate as key restraints to the growth of the global OTC drugs market over the forecast period. This report also provides the existing competitive scenario of some of the key players of the global OTC drugs market which includes company profiling ofBayer AG, Takeda Pharmaceutical Company Limited, Pfizer Inc., Johnson & Johnson Services, Inc., Sanofi US, Reckitt Benckiser Group PLC, Novartis AG, Boehringer Ingelheim International GmbH., GlaxoSmithKline plc., Glenmark Pharmaceuticals Limited, and others. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global OTC drugs market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future. Request Report Sample@ https://www.kennethresearch.com/sample-request- 10352513 Kenneth Research is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision in order to avoid future uncertainties.

4. Contact for more Info: AJ Daniel Email: sales@kennethresearch.com U.S. Phone: +1 313 462 0609